<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Basic fibroblast growth factor (bFGF) is an important growth factor involved in clonal hematopoietic expansion, neoangiogenesis, and bone marrow <z:mp ids='MP_0003045'>fibrosis</z:mp>, <z:hpo ids='HP_0000001'>all</z:hpo> of which are important pathobiologic features of clonal <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to assess circulating bFGF concentrations in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with respect to the presence of bone marrow <z:mp ids='MP_0003045'>fibrosis</z:mp> in histopathologic examination </plain></SENT>
<SENT sid="2" pm="."><plain>The study group comprised 18 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> (six female, 12 male; median age 50 years), seven patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (one female, six male; median age 66 years) and 10 healthy adults as controls (four female, six male; median age 29 years) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> group included six <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), seven <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> (ET), three <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>), two agnogenic <z:mpath ids='MPATH_173'>myeloid metaplasia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMM</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> seven <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were the FAB subtype of <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) </plain></SENT>
<SENT sid="5" pm="."><plain>Bone marrow biopsy sections stained with <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin (H &amp; E) and for reticulin were examined for the presence of <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The median plasma bFGF level was 18.2 pg/ml (interquartile range, IQR: 15.2-26.7) in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>, 18.0 pg/ml (IQR: 15.8-26.4) in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, 13.6 pg/ml (IQR: 9.9-20.0) in the control group </plain></SENT>
<SENT sid="7" pm="."><plain>The bFGF levels were significantly higher in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> in comparison with the healthy control group (P = 0.031) </plain></SENT>
<SENT sid="8" pm="."><plain>Circulating bFGF tended to be significantly lower in relation to the development of marrow <z:mp ids='MP_0003045'>fibrosis</z:mp> (P = 0.028) </plain></SENT>
<SENT sid="9" pm="."><plain>The complicated interactions of bFGF and <z:mp ids='MP_0003045'>fibrosis</z:mp> in the context of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> may be either 'cause' or 'effect' </plain></SENT>
<SENT sid="10" pm="."><plain>The bFGF might represent an important link between <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, <z:mp ids='MP_0003045'>fibrosis</z:mp>, and clonal neoplastic hematopoiesis during the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> </plain></SENT>
</text></document>